Although a lower PSA level after radical treatment is associated with a better prognosis in patients with prostate cancer [9, 14], the current study is the first study to show that decreasing 2-PSA compared with 1-PSA in patients without a history of prostate cancer decreases the risk of prostate cancer. The gene discussed is KLK3; the disease is prostate cancer.